Diploma’s (DPLM) “Buy” Rating Reiterated at Shore Capital

Shore Capital reaffirmed their buy rating on shares of Diploma (LON:DPLM) in a research report released on Thursday, Marketbeat reports.

DPLM has been the subject of several other research reports. Barclays reissued an overweight rating and issued a GBX 4,050 ($52.52) price target on shares of Diploma in a research note on Wednesday, May 15th. Deutsche Bank Aktiengesellschaft restated a buy rating and issued a GBX 4,500 ($58.36) price objective on shares of Diploma in a report on Tuesday, May 7th. Finally, Berenberg Bank upped their price objective on Diploma from GBX 4,400 ($57.06) to GBX 4,700 ($60.95) and gave the company a buy rating in a report on Monday, May 13th.

Diploma Trading Up 1.1 %

LON:DPLM opened at GBX 4,270 ($55.38) on Thursday. Diploma has a 1 year low of GBX 2,772.88 ($35.96) and a 1 year high of GBX 4,374 ($56.72). The stock has a market cap of £5.72 billion, a price-to-earnings ratio of 5,023.53, a PEG ratio of 2.82 and a beta of 0.73. The business has a fifty day moving average of GBX 4,163.92 and a 200-day moving average of GBX 3,707.85. The company has a debt-to-equity ratio of 45.69, a quick ratio of 0.80 and a current ratio of 2.27.

Diploma Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, June 7th. Stockholders of record on Thursday, May 23rd were issued a dividend of GBX 17.30 ($0.22) per share. This represents a dividend yield of 0.44%. The ex-dividend date was Thursday, May 23rd. Diploma’s dividend payout ratio is 6,705.88%.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.